Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke - Wikidata - wikimedia - TriplyDB

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

http://www.wikidata.org/entity/Q24656127

about

Sulfonylurea receptor 1 in central nervous system injury: a focused review Drugs acting on SUR1 to treat CNS ischemia and trauma Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.Human Data Supporting Glyburide in Ischemic Stroke.Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans.Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4.Glibenclamide for the treatment of ischemic and hemorrhagic stroke.Exploratory analysis of glyburide as a novel therapy for preventing brain swelling.Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.Non-selective cation channels, transient receptor potential channels and ischemic stroke.Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature.Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts Does inhibiting Sur1 complement rt-PA in cerebral ischemia?Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity.Mortality, Recurrence, and Dependency Rates Are Higher after Acute Ischemic Stroke in Elderly Patients with Diabetes Compared to Younger Patients.Sulfonylurea receptor 1 in the germinal matrix of premature infants.Short-Term High-Fat Diet (HFD) Induced Anxiety-Like Behaviors and Cognitive Impairment Are Improved with Treatment by Glyburide.Sulfonylurea receptor 1 expression in human cerebral infarcts.Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats.Glibenclamide for the treatment of acute CNS injury.Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke.Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Glibenclamide in cerebral ischemia and stroke Clinical predictors and management of hemorrhagic transformation.Malignant cerebral edema after large anterior circulation infarction: a review.Antidiabetic treatment, stroke severity and outcome Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways.Treatment of malignant brain edema and increased intracranial pressure after stroke.Effects of glucose-lowering agents on ischemic stroke.Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke.Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis Glyburide in Treating Malignant Cerebral Edema. Blocking Sulfonyl Urea One (SUR1) Receptors.Life after SAINT.

P2860

Q24606564-A00BAEC6-62C0-4917-841F-DB66FC82C15A Q24655850-AFCC7D14-749D-461F-8F16-5F2FD46FDF54 Q26825616-5592F7D4-D5BB-4D2A-B1FD-7B3B01D0808C Q28484475-89041ACC-A0E7-4512-99EF-F388C3161910 Q29144159-C0F502CF-D2F0-4202-AAA5-AD5473E507E3 Q30273785-5F3572E6-64A1-4E42-BE3C-44F092AC070B Q30273936-458006F1-594E-4CF0-846C-2127131A09F1 Q31004806-D8F6D65C-595B-4B3F-BB9A-F65F780F1152 Q33666517-5C56059F-76E4-470F-908D-6052D917D441 Q33863549-841058FB-E18C-4883-94AE-9AA6EB1E37F2 Q34522397-85B5FD17-F2A4-4BCC-8011-C6A230200066 Q34548221-70B5FF13-4B83-4620-8F78-0FB535F19CF4 Q35380697-D4928542-6DF2-4439-94CD-8541967D24A5 Q35619128-3958BBB5-9AA8-4605-899A-D976FBAF98D2 Q35901019-7273BB15-0F36-46D7-B628-093F2731C7BF Q36003275-D764E9E2-1E2A-43A8-AAC9-000C2B0457F9 Q36060634-B6BCC2EA-0E0E-44F0-9742-0ECFEDCEB8DA Q36204722-2C59287B-D735-4C0F-9AFE-18CDFB4CC913 Q36426567-CAD57280-2E78-455D-A631-D66B4B3A6056 Q36515347-B2B34B09-F526-47EA-8DA1-9124A19F313D Q36825406-6C6E8CE3-5623-47C6-8A76-9B675D1BD90C Q37009438-8FEEB5B8-3B80-4FD5-9C00-D41E2896AD07 Q37109014-A5C87CA4-240F-43D7-B344-41249EDA79D8 Q37166016-BF60EED8-C72D-4E63-8FED-2B65D0CA31CB Q37167025-30A111ED-B509-4EF8-9B2E-0F39925E6212 Q37240684-B671BAE7-F67F-47EE-BCC4-05E80CA51A5A Q37279993-7E27AEFF-0900-4957-9FF5-9FABD6F8E0F9 Q37347802-CAC5CCE7-A3AA-43BD-936D-AD9590029136 Q37508249-8028D83A-05F2-4274-9B92-49855444B7A2 Q37638478-6426536F-F0E0-401E-A36C-E531EAE0E4F1 Q38074569-34ECB951-38B4-4295-A318-EA98462B383C Q38175890-08237168-46DC-4833-B171-918D80F63612 Q38205762-B73D3F4E-2326-4DB6-8E8B-CA8721311C96 Q38250196-E013AC39-2A91-4643-A351-123D49EC314E Q38268315-71425316-66DB-4AA9-9B0F-F7A3DF69BA5F Q39427199-0CE69D23-FF83-449B-9575-F7C83714857B Q41461577-908618B2-AE0D-45F0-8E62-01260AADB4D6 Q41594953-3E6E2B96-37A8-498D-886D-75C799582400 Q41912082-013A3F69-7B76-49F0-B824-7AA2B8A87307 Q44411116-40F76A47-C6F9-4586-B7B5-1F6BA3F0C86B

P2860

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

http://www.wikidata.org/entity/Q24656127

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@ast

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@en

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@nl

type

label

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@ast

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@en

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@nl

prefLabel

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@ast

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@en

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@nl

P1433

Q24656127-8EFBCFFC-C714-40B0-A348-5512E7CA6B3F

P1476

Q24656127-9828CF75-5C01-4F27-88C1-37C534CA6382

P2093

Q24656127-133B8608-1F57-4AB1-9FF6-548BAEAAB238

Q24656127-7A6D2628-0718-4726-9B83-6395C5D1458D

Q24656127-82402F17-3601-46F6-B5F3-401C39C41A5F

Q24656127-9F304044-E1A3-4843-BCB8-AAFD59FBFB85

Q24656127-D03F56D5-C201-419C-84C8-275BB2CECF67

Q24656127-E49DABF0-5DC4-4091-9DF4-C1A616F47771

Q24656127-F07C7BBB-408A-4A99-943F-27DD312FA5D8

P2860

Q24656127-0945BA70-3A9B-4441-B068-B2425287054D

Q24656127-1F464FD9-4867-4F2C-92D1-900E6AA7F10F

Q24656127-2CBD6894-1333-450A-B85F-93C35FB1E0CA

Q24656127-330D979C-7E93-414D-A067-14E8B535A418

Q24656127-48DAB236-497E-4CE7-844A-F158416BDDCE

Q24656127-4E513CC6-0CF1-4674-8F18-22B24DC908CD

Q24656127-56B56DA4-699E-4C39-A7FF-D2537CCEC338

Q24656127-62A9F4A9-E2E6-49CE-A1C2-5539188F63F2

Q24656127-7FF48458-42F8-4B7C-8322-C57B3BBD9BDA

Q24656127-86AD600E-DA3D-4DF7-964A-92BC82A49D95

P304

Q24656127-4FEC92FA-073F-4E50-8678-F61AA2F7C0D2

P31

Q24656127-79B0CB00-824F-4CED-A716-874351BD2D96

P3181

Q24656127-3D4791AB-C36A-42C8-83C1-77E3D9CB5937

P356

Q24656127-A49C02E3-FD6F-4C81-9670-E919B796EE71

P407

Q24656127-59ED91D4-AB9E-41C0-8C46-DBCFEBEBC5A7

P433

Q24656127-E9BE9101-94ED-4F1E-A0E5-48E7930BD5E7

P478

Q24656127-1C280C45-9BE9-48CA-A109-DFF236CC3513

P50

Q24656127-09D71E36-0407-43A0-B227-DE7CBF2470F8

P577

Q24656127-CE2D1F38-DB76-43DA-B250-B66BFBCD72B3

P5875

Q24656127-3C186833-C956-4030-BA6F-3BB23544FE85

P698

Q24656127-97DCF10E-3DCE-4DFB-865E-789A9605E014

P921

Q24656127-29A436FC-F2BD-47E9-93A1-A6479775ACD7

Q24656127-5EF06AEA-B5BA-4E13-A27A-39D67E6D041C

P932

Q24656127-CACA8DE8-0C7E-4916-8DDF-CBC68E8D3B25

P3181

P356

STROKEAHA.107.482216

P1433

P1476

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

@en

P2093

Florian Masuhr

http://www.w3.org/2001/XMLSchema#string

Gregory J del Zoppo

http://www.w3.org/2001/XMLSchema#string

Hagen Kunte

http://www.w3.org/2001/XMLSchema#string

J Marc Simard

http://www.w3.org/2001/XMLSchema#string

Markus Weih

http://www.w3.org/2001/XMLSchema#string

Michael Eliasziw

http://www.w3.org/2001/XMLSchema#string

Sein Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke

Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality

Stroke prevention in diabetes and obesity

Tissue plasminogen activator for acute ischemic stroke

Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans.

ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies.

How important is hyperglycemia during acute brain infarction?

Hyperglycemia in acute ischemic stroke: a vascular perspective.

Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications

P304

2526-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

739429

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/STROKEAHA.107.482216

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6165114

http://www.w3.org/2001/XMLSchema#string

P698

17673715

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2742413

http://www.w3.org/2001/XMLSchema#string